Teva, Boehringer Trim 'Frankensteinian' Aggrenox Claims
A Connecticut judge on Monday kept intact most federal claims against Teva Pharmaceuticals USA Inc. and Boehringer Ingelheim Pharmaceuticals Inc. alleging a pay-for-delay scheme over a generic version of stroke drug...To view the full article, register now.
Already a subscriber? Click here to view full article